Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 5/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | PRCP | P42785 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.45 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.43 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28748865 | 1.00 | ACE (0.57) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL28918729 | 0.99 | ACE (0.58) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL18373911 | 0.99 | ACE (0.58) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL28918708 | 0.99 | ACE (0.58) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL28918671 | 0.99 | ACE (0.58) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL28748915 | 0.99 | ACE (0.58) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL31109309 | 0.98 | ACE (0.57) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL21302922 | 0.98 | ACE (0.57) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL28918703 | 0.98 | ACE (0.57) | ACEACE2OPRD1OPRM1PRCP | |
| SCHEMBL24519195 | 0.96 | ACE (0.55) | ACEACE2OPRD1OPRM1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114555106-B | Pharmaceutical formulation comprising sodium palmitoyl-L-prolyl-glycyl-L-tyrosine and process for its preparation | 毕利吉生物科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-114555106-A | Pharmaceutical formulations comprising sodium palmitoyl-L-prolyl-glycyl-L-tyrosinate and methods of making the same | 毕利吉生物科技股份有限公司 | 2022-05-27 | — | — | CN | disclosed |